Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index

BACKGROUND: CD4+ T lymphocyte (CD4) cell count testing is the standard method for determining eligibility for antiretroviral therapy (ART), but is not widely available in sub-Saharan Africa. Total lymphocyte counts (TLCs) have not proven sufficiently accurate in identifying subjects with low CD4 cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, David M, Awor, Anna, Downing, Robert S, Were, Willy, Solberg, Peter, Tu, David, Chan, Keith, Hogg, Robert S, Mermin, Jonathan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1796890/
https://www.ncbi.nlm.nih.gov/pubmed/17233896
http://dx.doi.org/10.1186/1742-6405-4-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1796890/
https://www.ncbi.nlm.nih.gov/pubmed/17233896
http://dx.doi.org/10.1186/1742-6405-4-1

Ejemplares similares